横向课题：《动物治疗性抗体的研制》乾元浩生物股份有限公司，2017-2021年，10万

国家自然科学基金委员会, 面上项目, 32172892, NDV rClone30-chGM-CSF疫苗通过JAK-STAT信号通路

缩短免疫空窗期的分子机制研究, 2022-01-01 至 2025-12-31, 58万元, 在研, 参与

(1) Jiechao Yin; Joerg Glende; Christel Schwegmann-Wessels; Luis Enjuanes; Georg Herrler; Xiaofeng Ren ; Cholesterol is important for a post-adsorption step in the entry process of transmissible gastroenteritis virus., Antiviral Research, 2010, 99(3): 311-316.

(2) Qi Yin; Xuelei Pi; Guiping Ren; Zhihang Liu; Han Liu; Mengxia Wang; Changhui Hu; Han Zhao; Deshan Li; Jiechao Yin ; A novel bispecific antibody alleviates bleomycin-induced systemic sclerosis injury, International Immunopharmacology, 2020, 85: 106644.

(3) Qi Yin; Xuelei Pi; Yuanyuan Jiang; Guiping Ren; Zhihang Liu; Han Liu; Mengxia Wang;Wenying Sun; Siyu Li; Zhenqiu Gao; Deshan Li; Jiechao Yin ; An immuno-blocking agent targeting IL-1β and IL-17A reduces the lesion of DSS-induced ulcerative colitis in mice, Inflammation, 2021, 44(5): 1724-1736. 

(4) Jinjiao He; Ziye Pan; Guiyou Tian; Xin Liu; Yunye Liu; Xiaochen Guo; Ying An; Liying Song; Hongsong Wu; Hongwei Cao; Dan Yu; Ruixiang Che; Pengfei Xu; Lubna M Rasoul; Deshan Li; Jiechao Yin ; Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy, Virus Research, 2016, (221): 23-29. 

(5) YanMin Chen; Yin Bai; XiaoChen Guo; WenFei Wang; Qi Zheng; FuXiang Wang; Dejun Sun; DeShan Li; GuiPing Ren; JieChao Yin ; Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library, Biologicals, 2016, 44: 271-275. 

任桂萍, 郭笑辰, 孙文影, 尹杰超. 一种多肽及其在预防鸡传染性法氏囊病中的应用. ZL 202011322122.4，中国，2021年。